Abstract. Nitric oxide (NO) synthesized from the inducible isoform of nitric oxide synthase (NOS-2) has been suggested to play both beneficial and deleterious roles in various neuropathologies. To define the role of nitric oxide in traumatic brain injury, we subjected male mice lacking a functional NOS-2 gene (NOS-2 Ϫ/Ϫ ) and their wild-type littermates (NOS-2 ϩ/ϩ ) to mild or severe aseptic cryogenic cerebral injury. Expression of NOS-2 mRNA and protein was observed in NOS-2 ϩ/ϩ animals following injury. Lesion volume (as measured by histology and brain imaging) and neurological outcome (using motor and cognitive behavioral paradigms) were assessed at various times after injury. While magnetic resonance imaging revealed the extent of edema of the 2 genotypes to be similar, histology showed a reduced (32%) lesion volume in severely injured NOS-2 Ϫ/Ϫ compared with NOS-2 ϩ/ϩ mice. In addition, NOS-2 Ϫ/Ϫ mice showed significant improvements in both contralateral sensorimotor deficits (grid test: p ϭ 0.011) and cognitive function (Morris water maze: p ϭ 0.009) after severe injury compared to their wild-type littermates. This indicates that lesion volume is reduced and neurological recovery is improved after acute traumatic injury in mice lacking a functional NOS-2 gene, and strongly suggests that the post-trauma production of NO from this source contributes to neuropathology.
INTRODUCTION
Nitric oxide synthases (NOS) comprise a group of enzymes that catalyze the conversion of L-arginine to Lcitrulline and nitric oxide (NO) (1) . Three isoforms have been identified: NOS-1, NOS-2, and NOS-3 (2-4). Both NOS-1 (Type I or nNOS) and NOS-3 (Type III or eNOS) are constitutively expressed and produce relatively small amounts of NO in response to a rise in intracellular calcium (5, 6) . The third isoform, NOS-2 (Type II or iNOS), can produce relatively large amounts of NO independently of changes in intracellular calcium concentration and can be expressed in the CNS by resident and infiltrating inflammatory cells (7) . The expression of NOS-2 is associated with viral, parasitic, and bacterial infections in multiple sclerosis and neurodegenerative diseases and following acute brain injury (8) .
While NO has many physiological roles, it has been shown to play a role in NMDA receptor-mediated neurotoxicity (9) (10) (11) . Excessive NO reacts rapidly with superoxide (O 2 Ϫ ) to form the highly cytotoxic peroxynitrite (ONOO Ϫ ) (12) , which, among other cell-damaging events, causes cell apoptosis and necrosis (13) . The link with neurotoxicity suggests that the expression of NOS-2 contributes to cellular loss. Furthermore, expression of NOS-2 coincides with the presence of inflammatory molecules and can be stimulated in vitro by pro-inflammatory cytokines, indicating a role in inflammation (14) . However, NO can also be neuroprotective. It can limit inflammation by decreasing production of cytokines and expression of cell adhesion molecules (15) (16) (17) (18) , and inhibit caspase activity (19) , suggesting an anti-apoptotic action. In addition, the activation of NOS-2 has been linked with neurogenesis (20, 21) , and NOS-2 inducing cytokines such as TNF-␣ and IL-1␤ display neuroprotective properties (22, 23) .
Traumatic brain injury (TBI) is a leading cause of death in young males, and NOS-2 expression is induced after such an event (24) . Whether NOS-2 contributes to pathology or to repair after TBI in human brain remains to be elucidated, and various experimental animal models of TBI have produced conflicting results (25) (26) (27) (28) (29) . Furthermore, the expression of NOS-2 following TBI may or may not correlate with the severity of injury, and therefore the extent of tissue damage. To resolve these issues we addressed the role of NO in the pathology associated with TBI using mice deficient in NOS-2 expression. Lesion volume may provide an indication of the extent of injury but the functional state of the remaining tissue is of paramount importance. Therefore, we have focussed on neurological recovery of these mice using a battery of well-characterized motor and cognitive tests. The outcome from this variety of measures is unequivocal: NOS-2-derived NO contributes to the structural and functional deficits following TBI.
ROLE OF NOS-2 IN ACUTE CEREBRAL INJURY
J Neuropathol Exp Neurol, Vol 63, July, 2004 dark cycle, with food and water available ad libitum. The founders of this colony were originally obtained from Merck Research Laboratories (Rahway, NJ) (30) . Genomic screening of animals was achieved by PCR using DNA extracted from either the tail or the ear, and this was performed prior to their use and again postmortem. Wild-type (ϩ/ϩ) mice were identified with primers that amplified a region within exon 1 of the NOS-2 gene (absent in Ϫ/Ϫ mice), and the genotype of Ϫ/Ϫ mice was confirmed using primers that amplified a region of the neo insert specific to the disrupted NOS-2 allele (absent in ϩ/ϩ mice).
Aseptic Cryogenic Cerebral Injury
Aseptic cryogenic cerebral injury (ACI) was achieved as previously described (31) . Briefly, male mice (8-12 weeks of age) were anesthetized with isofluorane (2%) in oxygen (2 L/min) and nitrous oxide (1 L/min). A midline sagittal incision of the scalp was made and cranial anatomy identified. Unilateral aseptic cryogenic injury of the right parietal cortex was induced by applying a cotton bud soaked in liquid nitrogen on the skull over the region for up to 15 seconds, resulting in a blanching of the skull surface. A 5-second application was defined as a mild insult, and a 15-second application as severe. The skin was then closed with 6-0 silk suture, and mice were allowed to recover for 30 to 60 min under a heating lamp. Sham surgeries were performed using the same technique, but without liquid nitrogen. All experiments were conducted in accordance with the UK Animals (Scientific Procedures) Act, 1986 (Project License 40/2206).
Behavioral Tasks
Grid Test: This test assesses contralateral sensorimotor deficits of animals (32) . From 6 hours up to 7 days after surgery, mice were placed on an elevated grid surface (35 cm wide ϫ 30 cm long, 31 cm high; 2.5 cm grid spaces). Subjects were acclimatized to the apparatus once immediately prior to surgery and the number of footfaults made by the ipsi-and contralateral limbs over a 60-second test period were manually counted.
Beam Balance: This test, developed for rats (33) and adapted for mice (34) , specifically assesses gross vestibular function (35) . From 6 hours up to 7 days after surgery, mice were placed on a suspended beam (6 mm wide and 30 cm long) elevated 15 cm. They were then rated on their ability to balance on the beam on a 6-point scale as follows: 5, balances on the beam with steady posture; 4, grasps the side of the beam and/or has unsteady movements; 3, hugs the beam without falling; 2, hangs on the beam without falling; 1, hangs on the beam and falls off; 0, does not attempt to balance on the beam. Animals were trained on the beam immediately prior to surgery until they achieved a rating of 5.
Rotarod: This test is commonly used to identify motor coordination and locomotor deficits in rats after TBI (36) and was modified for use in mice (37) . Animals were placed on a rotating rod (Rotarod, Letica Scientific Instruments, Barcelona, Spain) of 29 mm diameter, which accelerated from 4 rpm to 40 rpm over 120 seconds. Subjects were acclimatized to the task 3 times, including once immediately prior to surgery. This session was used to obtain control values (set as 100%) for each animal. From 6 hours up to 7 days after surgery, animals performed 5 trials on the apparatus (1-min inter-trial interval) and the time the animal stayed on the rod was recorded. The trial ended when the subject fell from the rotating rod, or gripped the device and spun around without attempting to walk on the rod. Mean values were generated and converted to a percentage of the presurgery control value.
Morris Water Maze: For the cognitive test, an adaptation of the Morris water maze (38) for mice was used. A fiberglass pool (138 cm diameter and 33 cm depth) was filled with opacified water maintained at 21ЊC Ϯ 1ЊC. Each subject was allowed to swim freely for 90 seconds in the pool on the day before the experiment commenced. A clear platform (10 cm ϫ 10 cm) was submerged 12 mm under the surface of the water and 31 cm from the edge of the pool in 1 of 4 different locations (north, south, east or west), which remained constant for each individual animal. Extra-visual cues were placed around the room, and the lighting was kept constant for every experiment. On day 15 after injury, animals were placed in the pool facing the wall at 1 of 4 possible starting locations (NE, NW, SE or SW) and given 90 seconds to locate the hidden platform. Once located, the subject was allowed to remain on the platform for 30 seconds. If the animal did not find the platform in the given time, it was guided to the platform and allowed to remain there for 30 seconds. For 6 consecutive days, each animal was given 2 sessions per day (4 trials per session) with an inter-trial interval of 30 min and an inter-session interval of 120 min. Swim speeds were obtained from the twelfth session, when the platform was removed and animals were entered into the middle of the pool for 90 seconds. Each trial was videotaped and movement was tracked by Ethovision software (Wageningen, Netherlands). Using this program, the length of time taken to reach the platform as well as swimming speed could be calculated.
Magnetic Resonance Imaging
At suitable time points after injury, animals were anesthetized with a mixture of 1 part Hypnorm and 1 part midazolam in 2 parts 0.9% saline (0.1 ml/10 g body weight ip), and placed on a holding cradle fitted with a heating device to maintain body temperature. TURBO RARE 3D coronal images (RARE factor ϭ 16) were obtained in 17.6 min on a Bruker Avance Biospec imaging system (Bruker Biospin MRI, Coventry, UK) at 2.35T using an effective TE of 62. for up to 7 days prior to analysis. Photos of each slice were taken using Axiovision (Carl Zeiss, Welwyn, UK), and lesion volume calculated using the computer program ScionImage (Frederick, MD), and defined as the area of white, unstained tissue. Three measurements were made of each slice and a mean value generated. Brain swelling was also corrected for by multiplying the lesion volume by the ratio of ipsilateral and contralateral hemispheric volumes of each individual slice.
Real Time RT-PCR
Wild-type mice were killed by cervical dislocation 24 hours after surgery, and brains removed and snap frozen in liquid nitrogen. The cerebellum was discarded and samples were stored at Ϫ80ЊC prior to use. Total RNA was isolated from each hemisphere using TriReagent (Sigma) according to the manufacturer's protocol. First strand cDNA was synthesized from 3 g RNA, using random primers (Promega, Southampton, UK) and Superscript III (Invitrogen, Paisley, UK) reverse transcriptase under the following conditions: 65ЊC for 5 min, 50ЊC for 60 min, and 70ЊC for 15 min. Additional reactions were performed in which the reverse transcriptase was omitted to allow for assessment of genomic DNA contamination and/or presence of pseudogenes. Reactions were carried out using an ABI prism 7,000 sequence detector (Applied Biosystems, Warrington, UK), with 2 l cDNA, 18 M each primer, 5 M probe, and Universal Taqman 2 ϫ PCR Mastermix (Applied Biosystems) to a final volume of 25 l. All samples were run in triplicate. Primers and MGB TaqMan probes (labeled with the fluorescent reporter FAM) for NOS-2, TNF-␣, and cyclophilin E were designed by Applied Biosystems (Assay-on-Demand) to avoid genomic amplification. The thermal cycling conditions used during the PCR were 2 min at 50ЊC, 10 min at 95ЊC, followed by 40 cycles at 95ЊC for 15 seconds and 60ЊC for 1 min. A standard curve was obtained for relative expression of the gene of interest and endogenous cyclophilin E, and a linear relationship was observed over a wide sample concentration (Ͼ500-fold). Cycle threshold (Ct) values for the target genes (NOS-2 and TNF-␣) were normalized to Ct values for endogenous cyclophilin E and final results were calculated according to the formula 2
Ϫ⌬⌬Ct
. Ipsilateral or contralateral hemispheres of a sham animal were used as calibrators, and NOS-2 or TNF-␣ mRNA was expressed relative to sham (ϭ 1).
Immunocytochemistry
For immunocytochemical evaluation, mice were anesthetized with an intraperitoneal injection of sodium pentobarbitone and transcardially perfused with 20 ml 0.9% saline and 1 ml/g body weight fixative solution, consisting of 4% paraformaldehyde and 15% picric acid in phosphate buffered saline adjusted to pH 7.4. Brains were removed and postfixed for 2 hours at 4ЊC before being transferred to 30% sucrose solution in PBS and kept overnight at 4ЊC. Brains were placed on corkboards and frozen in Tissuetek (Sakura, Newbury, UK) at Ϫ80ЊC. Coronal sections (25 m) were cut using a cryostat and mounted on APES-or gelatin-coated slides, air-dried overnight, and stored at Ϫ80ЊC until used. Some sections were Nissl stained with cresyl violet solution. The expression of NOS-2 protein and identity of activated macrophages/microglia and neutrophils were confirmed using an immunoperoxidase technique, as previously described (31) . Briefly, sections were incubated in appropriate primary antibodies diluted in PBST (PBS with 0.1% Triton X-100, Sigma) with 3% appropriate serum; NOS-2 (1: 1,000, rabbit polyclonal, Chemicon, Chandlers Ford, UK); MOMA-2 (MCA 519, 1:5, rat polyclonal, Serotec, Kidlington, UK); myeloperoxidase (MPO, 1:200, rabbit polyclonal, kindly donated by DAKO, Ely, UK). This was followed by incubation in appropriate biotinylated secondary antibodies: goat anti-rabbit (1:800, Sigma) and rabbit anti-rat (1:100, Vector Labs, Peterborough, UK). Sections were washed and incubated for 1 hour in streptavidin-HRP (5 g/ml in PBST, Vector Labs). Following further washing, slides were reacted with 3 l/ml hydrogen peroxide and 50 l/ml diaminobenzidine in PBS for 20 min and then washed in PBS. Slides were then dehydrated, cleared, and coverslipped in Entellan (Merck, Hoddesdon, UK).
Statistics
For analysis of mRNA data, paired t-tests were used to assess differences of individual groups compared to sham controls and two-way ANOVAs were used to concurrently test for hemispheric and treatment severity statistical differences, with Bonferroni's multiple comparison post-hoc analysis. For comparison of lesion volume, two-way ANOVAs were used to concurrently test for statistical differences in treatment severity and genotype, with Bonferroni's multiple comparison post-hoc analysis. For all behavioral experiments, two-way ANOVA's were performed to test for differences between genotypes or between different severities of injury, with post-hoc analysis achieved using Bonferroni's multiple comparison test. In all instances, statistical significance was defined as p Ͻ 0.05. All statistics were performed using GraphPad Prism Version 3.00 for Windows (Graph Pad Software, San Diego, CA).
RESULTS

Cryogenic Injury Induces Expression of NOS-2
The freeze lesion resulted in a marked loss of cellular tissue at the injury site, as depicted by cresyl violet staining (Fig. 1 ). As we have described previously (31) , an elliptical and well-circumscribed acellular area of cortical necrosis was seen, delimited by a rim of reactive astrocytes. Hemorrhage and edema were evident subjacent to the lesion. Within 24 to 48 hours, infiltrating cells (neutrophils and macrophages) were evident within the lesion and the overlying meninges (Fig. 1vii) . Reactive astrocytosis extended into the underlying parenchyma. With time the acellular area of the lesion reduced and, by day 21, was hard to discern ( Fig. 1i-iii) . Even a severe lesion did not affect gross behavioral characteristics (feeding patterns, weight changes, mobility, physical appearance). Two animals died during the study, both after mild surgery (1 wild-type and 1 NOS-2 Ϫ/Ϫ ). The mice lost a small proportion of their body weight (ϳ3%) after surgery, but this was regained within 7 days (data not shown). Since weight loss also occurred in sham-operated animals, this was attributed to the anesthetic. The expression of NOS-2 and TNF-␣ mRNA, relative to cyclophilin E, was quantified 24 hours after injury (Fig. 2) . We confirmed that the expression of cyclophilin E was unaffected by the injury status (data not shown), as variation in reference genes can be problematic (39) . Expression of NOS-2 mRNA was detected in both ipsiand contralateral hemispheres of mild (n ϭ 5) and severely injured (n ϭ 3) wild-type mice, and levels were significantly higher after severe injury when compared to sham (ipsilateral hemisphere: p ϭ 0.0394; contralateral hemisphere: p ϭ 0.0295). The bilateral expression of NOS-2 mRNA is consistent with our previous findings (31) . Expression of the pro-inflammatory cytokine and NOS-2 inducer, TNF-␣, was also strongly upregulated in both hemispheres, and TNF-␣ expression correlated with the severity of injury (F (1, 16) ϭ 27.25; p ϭ 0.0014). Furthermore, ipsilateral TNF-␣ expression was significantly greater than contralateral (F (1,16) ϭ 17.08; p ϭ 0.0002), and this reached post-hoc significance after severe surgery (p Ͻ 0.05).
Scattered cells expressing NOS-2 protein were observed in both mild and severely injured mice (Fig. 2B) , as we have reported previously (31) . Beginning 12 hours postinjury, these were small round cells without processes present in the meninges above the lesion, in the lesion site, and in the cortex adjacent to the lesion. Morphologically, these resembled infiltrating polymorphonuclear and mononuclear inflammatory cells, and they were present in greatest number at 12 to 24 hours postinjury, although a few positive cells were still present 14 days later. Immunostaining with MPO and MOMA-2 antibodies, performed on sections adjacent to those found to contain NOS-2-positive cells, indicated these cells to be invading neutrophils and activated macrophages/microglia. These cells also surrounded the lesion border and were present in local vessels. No cells positive for NOS-2, MPO, or MOMA-2 were seen in contralateral hemispheres or in sham treated mice.
Lesion Size Is Reduced in NOS-2
Ϫ/Ϫ Animals after ACI
The T2-weighted coronal scanning of injured mouse brain allowed visualization of various brain regions, such as the corpus callosum and cerebral ventricles, and also revealed a hyperintense region localized to the right parietal cortex that was indicative of edematous tissue resulting from injury (Fig. 3A) . The extent of edematous tissue appeared greatest 2 days after surgery, and calculation of the volume of hyperintensity at this time showed that increasing the severity of injury significantly increased the extent of edema formation (F (1, 17) ϭ 0.0044, sample sizes: wild-type (WT) Ϫ mild ϭ 3, severe ϭ 5; NOS-2 knockout (KO) Ϫ mild ϭ 4, severe ϭ 5; Fig. 3B ). However, no significant differences were observed between wild-type and NOS-2 Ϫ/Ϫ animals after mild or severe lesions (F (1, 17) ϭ 0.28; p ϭ 0.6076), indicating that the NOS-2 gene plays no major part in the formation of edema after ACI.
Staining with TTC 2 days after injury revealed a distinct area of necrotic tissue (Fig. 4A) , and this area was significantly increased in severe vs mild injury ( Representative coronal T2-weighted magnetic resonance images of a severely lesioned wild-type mouse brain 2, 7, and 13 days after ACI. The damaged area is clearly defined as a hyperintense region over the right parietal cortex, indicating edema formation. This edema subsided over time, leaving a hypointense (dark) region suggestive of a hematoma. B: Mean edema measurements (Ϯ SEM) after mild or severe ACI in wild-type and NOS-2 Ϫ/Ϫ animals as measured by T2-weighted abnormality of magnetic resonance images 48 hours after insult. Number of animals used is indicated in parentheses. While increasing severity of injury significantly increased edema formation (p ϭ 0.0044), no difference was observed between the 2 genotypes for either severity of injury. much reduced (Fig. 4A) , and was no longer evident at 21 days after injury (data not shown). While cresyl violet staining revealed the remnant of the lesion 21 days after injury (Fig. 1A) , this was not readily quantifiable. Comparing results from the 2 genotypes, the volume of necrosis at 2 days postinsult was significantly larger in the wild-type compared to NOS-2 Ϫ/Ϫ mice (F (1,16) ϭ 10.23; p ϭ 0.0076, Fig. 4B ). This difference (32%) reached posthoc significance after severe injury (p Ͻ 0.05), indicating that the NOS-2 Ϫ/Ϫ animals were protected against a cortical freeze lesion.
Contralateral Sensorimotor Deficits Are Reduced in NOS-2 Ϫ/Ϫ Mice after ACI When performing the grid test (Fig. 5) , mild and severely injured animals from both genotypes displayed a greater percentage of footslips on their contralateral limbs when compared to sham controls (wild-type Ϫ F (2,15) ϭ 12.97; p Ͻ 0.0001, sample sizes ϭ 5 for all groups; NOS-2 Ϫ/Ϫ Ϫ F (2,15) ϭ 41.38; p Ͻ 0.0001, sample sizes: sham ϭ 6, mild ϭ 5, severe ϭ 4). When comparing genotypes, NOS-2 Ϫ/Ϫ mice showed a significantly decreased percentage of errors on the contralateral side after severe injury (F (1,9) ϭ 7.188; p ϭ 0.0104), but not after mild injury (F (1, 9) ϭ 0.068; p ϭ 0.796). Maximum differences occurred at 6 hours after severe injury, when percentages of contralateral errors were wild-type 84.0 Ϯ 7.2% and NOS-2 Ϫ/Ϫ 70.8 Ϯ 4.4% (Fig. 5B ). The beam balance (Fig. 6 ) and Rotarod tests (Fig. 7) revealed marked disturbances to the balance and motor coordination of mild and severely injured animals of both Ϫ/Ϫ Ϫ F (2,15) ϭ 5.268; p ϭ 0.0075), and these deficits persisted for 7 days. However, there were no significant differences between genotypes on the beam balance (severe injury: F (1, 9) ϭ 0.6272; p ϭ 0.4328) or Rotarod (severe injury: F (1, 9) ϭ 0.0009; p ϭ 0.798) after either mild or severe injury. While these gauge gross vestibular and locomotor function, the grid test, which demonstrated the functional improvement in NOS-2-deficient mice after ACI, is more sensitive to lateral deficits.
Absence of Cognitive Deficits in NOS-2
Ϫ/Ϫ Mice after ACI Wild-type animals subjected to ACI displayed a significantly increased latency in locating the hidden platform in the water maze over time when compared to sham controls (F (2,15) ϭ 4.463; p ϭ 0.0149, sample sizes ϭ 5 for all groups, Fig. 8B ). Interestingly, no such impairment was observed for NOS-2 Ϫ/Ϫ animals after injury (F (2,14) ϭ 1.085; p ϭ 0.3438, sample sizes: sham ϭ 5, mild ϭ 4, severe ϭ 4, Fig. 8C ). There was no difference between wild-type and NOS-2 Ϫ/Ϫ animals after sham surgery in their ability to locate the hidden platform in the water maze (F (1, 11) ϭ 0.3953; p ϭ 0.5322, Fig. 8A ). However, after mild injury, NOS-2 Ϫ/Ϫ animals performed significantly better than wild-type animals in their ability to locate the platform (F (1,9) ϭ 5.485; p ϭ 0.024, Fig. 8D ), and this difference was even more dramatic after severe injury (F (1,9) ϭ 7.343; p ϭ 0.0097, Fig. 8E ). The impairment of wild-type mice in this test was not due to reduced swimming ability, since the calculated swim speeds were independent of genotype (F (1,29) ϭ 1.608; p ϭ 0.2175) and injury (F (2, 29) ϭ 0.1051; p ϭ 0.9007, data not shown).
DISCUSSION
The purpose of this study was to characterize neurological outcome in mice following TBI and to determine the contribution of NOS-2 to the ensuing pathology. One established experimental model of TBI is ACI, which has been used previously in our laboratory (31) and by others in a variety of species (40, 41) . This model features a highly reproducible disruption of the blood-brain barrier and formation of cerebral edema, leading to secondary brain damage. While behavioral characterizations of the fluid-percussion (FP) and controlled cortical impact (CCI) models of TBI are extensive, little is known about behavioral deficits of cryogenically injured animals. Here we show, for the first time, that ACI in mice produces severity-dependent behavioral deficits in motor co-ordination and cognitive processes, similar to those seen in other models of TBI (see ref 42, 43 for comparative examples), and confirm that cryogenic lesion produces pathology that can be viewed by MRI (41, 44, 45) . Furthermore, this injury is associated with a strong inflammatory response, as revealed by TNF-␣ and NOS-2 mRNA upregulation. In addition, it is clear that NOS-2 Ϫ/Ϫ male mice exhibit a more favorable outcome, suggesting that NO produced from NOS-2 contributes to the neuropathology following ACI.
After traumatic insult, pro-inflammatory cytokines such as TNF-␣ and IL-1␤ are rapidly activated (46) . Among other things, these promote expression of NOS-2 in infiltrating cells and in resident glia, leading to the local production of NO. The disruption of the blood-brain barrier, and subsequent infiltration of circulating immunocompetent cells into the brain parenchyma, contribute to inflammation and edematous swelling of the damaged area (47) . Secondary damage occurs through necrotic and apoptotic cell death (48) , leading to neuronal degeneration and loss of brain function, and ultimately physical disability. Interfering with the secondary damage cascade, over which NO has a large influence, could lead to reduced tissue loss and limited disruption of neurological function.
Expression of NOS-2 has been reported in both human casualties (24, 49) and in animal models of traumatic brain or spinal cord injury (25, 29, 31, 40, (50) (51) (52) (53) (54) (55) . Here we show that the ability of mice to express NOS-2 after ACI leads to more extensive cell damage and greater impairment of neurological function compared with NOS-2 incompetent animals. The detrimental effect of NO produced by NOS-2 in this model could possibly be a result of the production of peroxynitrite (ONOO Ϫ ). This potent oxidant produces a wide array of cell-damaging effects, including nitration and oxidation of biologically important proteins (56) , mitochondrial dysfunction (57), lipid peroxidation (58) , and DNA damage (59) , culminating in cell apoptosis and necrosis (13) . Previous studies have shown an increase in ONOO Ϫ after CNS injury (54, 60- Ϫ/Ϫ (B) mice after sham, mild, or severe ACI at various times following injury (n Ͼ 4 for all groups). Both genotypes displayed a significantly reduced ability to balance and traverse across the beam after injury, and this deficit was dependent on the severity. However, no differences were observed between genotypes. Ϫ/Ϫ (B) animals to remain on an accelerating rotating rod after sham, mild or severe ACI at various times following injury, expressed as percent of pretrauma latency (n Ͼ 4 for all groups). After severe injury, both genotypes displayed a significantly reduced ability to stay on the Rotarod, but no difference between genotypes was observed. 63 ). While most of the cytotoxicity and oxidative stress associated with NO may be attributed to ONOO Ϫ , NO can also directly affect mitochondrial function (64) .
Genetically engineered animals have been utilized to investigate TBI on many occasions (65) and, since NOS-2 is heavily implicated in the pathophysiology of this injury, the NOS-2-deficient mouse is an ideal model for a study of the potential protective or damaging effects of the resulting NO. The detrimental role of NO observed here is supported by previous reports that show NOS-2 deletion to be beneficial in ischemic insult (66) (67) (68) (69) (70) , gut barrier dysfunction (71) , and in models of hepatotoxicity (72) . However, in other disease models, NOS-2 Ϫ/Ϫ mice displayed exacerbated deficits, such as in CCI-induced TBI (25) , liver ischemia/reperfusion injury (73), neointima formation (74), ozone-induced (75) , and hyperoxiainduced (76) lung injury, illustrating the well-documented dichotomy of the action of NOS-2 after injury. After severe ACI, we found lesion volume, as measured by TTC staining, to be reduced by 32% in NOS-2-deficient animals, a finding supported by Gorlach et al (27) who demonstrated that a NOS inhibitor (aminoguanidine) reduced lesion volume after cold injury in rats, and others who have shown this compound to be protective in different models of experimental trauma in rats (11, (26) (27) (28) (29) . Ϫ/Ϫ (C) animals to locate a hidden platform on days 15 to 20 after sham (A), mild (D), or severe (E) ACI (n ϭ 5 for all groups). Data are replicated to allow comparison between genotypes. While wildtype animals showed a severity-dependent increase in latency to locate the platform (B), even severe injury had no effect on latency for NOS-2 Ϫ/Ϫ mice (C). No difference was observed between sham groups (A), but after mild and severe injury, NOS-2 Ϫ/Ϫ mice had significantly reduced latencies when locating the platform compared to wild-type animals (*p ϭ 0.024 after mild injury, panel D; *p ϭ 0.009 after severe injury, panel E).
Edema formation is a common trait of TBI, contributes to brain damage, and can be visualized and measured by various techniques such as T2-weighted MRI. Here we found that the extent of edema formation after ACI is dependent on the severity of injury, but not on the ability of mice to express NOS-2, since no difference in the volume of edema exists between NOS-2 Ϫ/Ϫ and wild-type mice. However, we did not examine edema resolution. Administration of lubeluzole, a NOS pathway modulator, or FK506, an immunosuppressant that inhibits NOS-2 expression (77), had no effect on the formation of brain edema in rats after CCI (78, 79) , which supports our finding. However, others have shown that treatment of rats with aminoguanidine after fluid-percussion injury (26) or ischemic insult (80) reduced T2-weighted abnormality significantly compared to vehicle-treated animals, suggesting that NO affects edema formation in models of brain injury differently. Using T2-weighted scans, MRI has been previously used to visualize and quantify injury after an experimental traumatic lesion (41, 44, 81) , and reports suggest that such measures are closely correlated with actual lesion volume (26, 82, 83) . This does not seem to be true of ACI, since the ''damage'' measured by MRI in the current study did not correlate with histological examination of brains stained with TTC. One explanation for this is that T2-weighted images 2 days after ACI highlight areas of edematous tissue, whereas absence of TTC staining reflects necrotic tissue. Others have suggested that diffusion-weighted images represent a more accurate correlation between areas of abnormality and histology after closed head injury (84) , and it remains to be seen whether this is the case after ACI.
Following ACI, wild-type mice showed a decreased learning ability to locate a hidden platform in the Morris water maze. Since the lesion is primarily cortical, this implies that the integrity of cortical projections to the hippocampus must be preserved in order to perform this task and form new memories. The NOS-2 Ϫ/Ϫ mice retained their ability to learn to locate a hidden platform after repeated trials in the Morris water maze task, suggesting functional preservation of cortical/hippocampal neurons after injury. Protection also correlated with a decrease in contralateral limb errors (as measured in the grid test) when compared to wild-type animals. Behavioral recovery after TBI has previously been shown to be improved in rats treated with aminoguanidine, supporting our findings (26) . In the only previous study using NOS-2-deficient mice to investigate TBI, Sinz et al (25) described improved behavioral outcome in wild-type mice and proposed a beneficial role for NOS-2. However, only cognitive and not motor behaviors were improved in that study, and no difference in lesion volume was observed after injury between the different genotypes. Their study also used ''selective'' NOS-2 inhibitors, although the specificity of the compounds used for NOS-2 is questionable (85) . Inhibition of the different isoforms of NOS can lead to contrasting outcomes (86) , and nonspecific inhibition could, therefore, compromise interpretation of results. However, it should be noted that lesion volume was estimated at different time points, and Sinz et al (25) used CCI, a different model of TBI. Cellular pathology of models of TBI can take on different time courses (87) , which could play a role in the different responses of NOS-2 Ϫ/Ϫ mice to injury. To conclude, here we show that aseptic cerebral injury produces motor and cognitive behavioral deficits in male mice, and that these deficits are not as apparent or are even absent in mice deficient in NOS-2 expression. These findings reinforce the need for truly specific NOS-2 inhibitors to limit pathology following traumatic brain injury.
